Alpha 2.0
Login Register
» Articles » PMID: 16157822

Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration: Four-year Results of an Open-label Extension of 2 Randomized Clinical Trials: TAP Report No. 7

Overview
Journal Arch Ophthalmol
Publisher American Medical Association
Specialty Ophthalmology
Date 2005 Sep 15
PMID 16157822
Citations 10
Authors
Neil M Bressler
Susan B Bressler
Laurie A Haynes
Yong Hao
Peter K Kaiser
Joan W Miller
Joel Naor
Michael J Potter
Constantin J Pournaras
Al Reaves
Philip J Rosenfeld
Ursula Schmidt-Erfurth
Jason S Slakter
Andrew Strong
Stephane Vannier
Affiliations
Soon will be listed here.
Citing Articles

Decreased Visual Function Scores on a Low Luminance Questionnaire Is Associated with Impaired Dark Adaptation.

Yazdanie M, Alvarez J, Agron E, Wong W, Wiley H, Ferris 3rd F Ophthalmology. 2017; 124(9):1332-1339.

PMID: 28602520 PMC: 8279728. DOI: 10.1016/j.ophtha.2017.05.005.

Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.

Ong F, Kuo J, Wu W, Cheng C, Blackwell W, Taylor B J Pers Med. 2014; 3(1):40-69.

PMID: 24624293 PMC: 3947950. DOI: 10.3390/jpm3010040.

Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration.

Riazi-Esfahani M, Ahmadieh H, Faghihi H, Piri N, Taei R, Karkhaneh R J Ophthalmic Vis Res. 2013; 3(2):95-101.

PMID: 23479530 PMC: 3589227.

Topographical Choroidal Thickness Change Following PDT for CSC: An OCT Case Report.

Wirostko W, Nordgren R, Dubis A J Ophthalmol. 2012; 2012:347206.

PMID: 22292111 PMC: 3265181. DOI: 10.1155/2012/347206.

Treatment of age-related macular degeneration: focus on ranibizumab.

Spitzer M, Ziemssen F, Bartz-Schmidt K, Gelisken F, Szurman P Clin Ophthalmol. 2009; 2(1):1-14.

PMID: 19668384 PMC: 2698673. DOI: 10.2147/opth.s1959.